{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:56:37Z","timestamp":1794264997609,"version":"4.9.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1053\/j.gastro.2024.11.023","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T12:31:41Z","timestamp":1734611501000},"page":"701-713.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Glepaglutide, a Long-Acting Glucagon-like Peptide-2 Analogue, Reduces Parenteral Support in Patients With Short Bowel Syndrome: A Phase 3 Randomized Controlled Trial"],"prefix":"10.1053","volume":"168","author":[{"given":"Palle B.","family":"Jeppesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Vanuytsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukanya","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Wanten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Lamprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Kunecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farooq","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor S.S.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Berner-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich-Frank","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2024.11.023_bib1","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.cgh.2022.05.032","article-title":"AGA clinical practice update on management of short bowel syndrome: expert review","volume":"20","author":"Iyer","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.11.023_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clnu.2016.01.020","article-title":"ESPEN guidelines on chronic intestinal failure in adults","volume":"35","author":"Pironi","year":"2016","journal-title":"Clin Nutr"},{"key":"10.1053\/j.gastro.2024.11.023_bib3","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.clnu.2018.07.036","article-title":"Intestinal failure in adults: recommendations from the ESPEN expert groups","volume":"37","author":"Pironi","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1053\/j.gastro.2024.11.023_bib4","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1177\/0148607114520994","article-title":"Spectrum of short bowel syndrome in adults: intestinal insufficiency to intestinal failure","volume":"38","author":"Jeppesen","year":"2014","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1053\/j.gastro.2024.11.023_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clnu.2014.08.017","article-title":"ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults","volume":"34","author":"Pironi","year":"2015","journal-title":"Clin Nutr"},{"key":"10.1053\/j.gastro.2024.11.023_bib6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/00365529609094567","article-title":"Nutrition in short-bowel syndrome","volume":"216","author":"Ladefoged","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2024.11.023_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cgh.2005.10.002","article-title":"Short bowel syndrome and intestinal failure: consensus definitions and overview","volume":"4","author":"O'Keefe","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.11.023_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2147\/CEG.S13906","article-title":"Emerging treatment options for short bowel syndrome: potential role of teduglutide","volume":"4","author":"Tee","year":"2011","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1053\/j.gastro.2024.11.023_bib9","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1017\/S0007114511004582","article-title":"Long-term impact of infantile short bowel syndrome on nutritional status and growth","volume":"107","author":"Olieman","year":"2012","journal-title":"Br J Nutr"},{"key":"10.1053\/j.gastro.2024.11.023_bib10","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/jpen.2372","article-title":"Impact of intestinal failure and parenteral support on adult patients with short-bowel syndrome: a multinational, noninterventional, cross-sectional survey","volume":"46","author":"Jeppesen","year":"2022","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1053\/j.gastro.2024.11.023_bib11","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.12968\/bjon.2022.31.6.S48","article-title":"Impact of stoma leakage in everyday life: data from the Ostomy Life Study 2019","volume":"31","author":"Jeppesen","year":"2022","journal-title":"Br J Nurs"},{"key":"10.1053\/j.gastro.2024.11.023_bib12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/jpen.1958","article-title":"High parenteral support volume is associated with reduced quality of life determined by the Short-Bowel Syndrome Quality of Life Scale in nonmalignant intestinal failure patients","volume":"45","author":"Nordsten","year":"2021","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1053\/j.gastro.2024.11.023_bib13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/gut.46.5.701","article-title":"Intestinal failure defined by measurements of intestinal energy and wet weight absorption","volume":"46","author":"Jeppesen","year":"2000","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.11.023_bib14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.mog.0000153348.41031.b5","article-title":"Parenteral nutrition","volume":"21","author":"Forbes","year":"2005","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1053\/j.gastro.2024.11.023_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/MOT.0b013e32832ac06f","article-title":"Some new insights in intestinal failure-associated liver disease","volume":"14","author":"Goulet","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1053\/j.gastro.2024.11.023_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clnu.2005.09.010","article-title":"Chronic dehydration may impair renal function in patients with chronic intestinal failure on long-term parenteral nutrition","volume":"25","author":"Lauverjat","year":"2006","journal-title":"Clin Nutr"},{"key":"10.1053\/j.gastro.2024.11.023_bib17","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1016\/j.clnu.2021.07.002","article-title":"ESPEN practical guideline: clinical nutrition in chronic intestinal failure","volume":"40","author":"Cuerda","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1053\/j.gastro.2024.11.023_bib18","doi-asserted-by":"crossref","first-page":"170924","DOI":"10.1016\/j.peptides.2022.170924","article-title":"Four sidenotes about glucagon peptides","volume":"159","author":"Rehfeld","year":"2023","journal-title":"Peptides"},{"key":"10.1053\/j.gastro.2024.11.023_bib19","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1007\/s10620-019-05779-0","article-title":"The long road to the development of effective therapies for the short gut syndrome: a personal perspective","volume":"64","author":"Jeppesen","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2024.11.023_bib20","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1053\/gast.2001.22555","article-title":"Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon","volume":"120","author":"Jeppesen","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.11.023_bib21","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1073\/pnas.93.15.7911","article-title":"Induction of intestinal epithelial proliferation by glucagon-like peptide 2","volume":"93","author":"Drucker","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2024.11.023_bib22","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/jpen.1767","article-title":"Effect of glepaglutide, a long-acting glucagon-like peptide-2 analog, on gastrointestinal transit time and motility in patients with short bowel syndrome: findings from a randomized trial","volume":"44","author":"Hvistendahl","year":"2020","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1053\/j.gastro.2024.11.023_bib23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2036.2006.03193.x","article-title":"Review article: glucagon-like peptide 2\u2014current applications and future directions","volume":"25","author":"Wallis","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2024.11.023_bib24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.gastro.2005.10.004","article-title":"Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans","volume":"130","author":"Meier","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.11.023_bib25","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1210\/jcem.84.7.5840","article-title":"Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2","volume":"84","author":"Wojdemann","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.gastro.2024.11.023_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/gut.47.1.112","article-title":"Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse","volume":"47","author":"Benjamin","year":"2000","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.11.023_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1042\/bj20020393","article-title":"Rapid insertion of GLUT2 into the rat jejunal brush-border membrane promoted by glucagon-like peptide 2","volume":"367","author":"Au","year":"2002","journal-title":"Biochem J"},{"key":"10.1053\/j.gastro.2024.11.023_bib28","first-page":"R1965","article-title":"Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo","volume":"273","author":"Cheeseman","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1053\/j.gastro.2024.11.023_bib29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0016-5085(03)00667-X","article-title":"GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets 1","volume":"125","author":"Guan","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.11.023_bib30","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1007\/s10620-020-06140-6","article-title":"Teduglutide promotes epithelial tight junction pore function in murine short bowel syndrome to alleviate intestinal insufficiency","volume":"65","author":"Reiner","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2024.11.023_bib31","doi-asserted-by":"crossref","first-page":"E134","DOI":"10.1152\/ajpendo.2000.278.1.E134","article-title":"Enzymatic- and renal-dependent catabolism of the intestinotropic hormone glucagon-like peptide-2 in rats","volume":"278","author":"Tavares","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1053\/j.gastro.2024.11.023_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0196-9781(99)00176-X","article-title":"Structure, measurement, and secretion of human glucagon-like peptide-2","volume":"21","author":"Hartmann","year":"2000","journal-title":"Peptides"},{"key":"10.1053\/j.gastro.2024.11.023_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s40265-017-0703-7","article-title":"Teduglutide: a review in short bowel syndrome","volume":"77","author":"Kim","year":"2017","journal-title":"Drugs"},{"key":"10.1053\/j.gastro.2024.11.023_bib34","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s40261-022-01210-1","article-title":"Pharmacokinetics of glepaglutide, a long-acting glucagon-like peptide-2 analogue: a study in healthy subjects","volume":"42","author":"Agersnap","year":"2022","journal-title":"Clin Drug Investig"},{"key":"10.1053\/j.gastro.2024.11.023_bib38","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s40262-023-01215-9","article-title":"Pharmacokinetics, safety, and tolerability of glepaglutide, a long-acting GLP-2 analog, in subjects with renal impairment","volume":"62","author":"Agersnap","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"10.1053\/j.gastro.2024.11.023_bib39","unstructured":"U.S. Food & Drug Administration. Patient-focused drug development guidance public workshop: methods to identify what is important to patients & select, develop or modify fit-for-purpose clinical outcomes assessments. Workshop date: October 15\u201316, 2018. Attachment to discussion document. Available at: https:\/\/www.fda.gov\/media\/116281\/download. Accessed January 15, 2025."},{"key":"10.1053\/j.gastro.2024.11.023_bib40","unstructured":"U.S. Food & Drug Administration. Patient-focused drug development guidance public workshop: methods to identify what is important to patients & select, develop or modify fit-for-purpose clinical outcomes assessments. Workshop date: October 15\u201316, 2018. Discussion document. Available at: https:\/\/www.fda.gov\/media\/116277\/download. Accessed January 15, 2025."},{"key":"10.1053\/j.gastro.2024.11.023_bib41","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1200\/JCO.2010.30.2307","article-title":"Phase I study of vorinostat in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study","volume":"28","author":"Ramalingam","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.gastro.2024.11.023_bib42","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/j.ajkd.2021.08.003","article-title":"A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease","volume":"79","author":"Delgado","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.gastro.2024.11.023_bib43","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1053\/gast.2000.20227","article-title":"Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans","volume":"119","author":"Crenn","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.11.023_bib44","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/gut.2010.218271","article-title":"Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and\/or intravenous fluid requirements in patients with short bowel syndrome","volume":"60","author":"Jeppesen","year":"2011","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.11.023_bib45","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1053\/j.gastro.2012.09.007","article-title":"Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure","volume":"143","author":"Jeppesen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.11.023_bib46","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S2468-1253(19)30077-9","article-title":"Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial","volume":"4","author":"Naimi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.11.023_bib47","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820905766","article-title":"Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials","volume":"13","author":"Pape","year":"2020","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1053\/j.gastro.2024.11.023_bib48","series-title":"Gattex (teduglutide). US prescribing information","year":"2024"},{"key":"10.1053\/j.gastro.2024.11.023_bib49","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/jpen.2221","article-title":"Characterization of American teduglutide consumers from 2015 to 2020: a large database study","volume":"46","author":"Loutfy","year":"2022","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1053\/j.gastro.2024.11.023_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.regpep.2011.03.003","article-title":"The effect of glucagon-like peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients","volume":"168","author":"Bremholm","year":"2011","journal-title":"Regul Pept"},{"key":"10.1053\/j.gastro.2024.11.023_bib51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jpen.1011","article-title":"Single-center experience with the use of teduglutide in adult patients with short bowel syndrome","volume":"42","author":"Lam","year":"2018","journal-title":"JPEN J Parenter Enteral Nutr"}],"updated-by":[{"DOI":"10.1053\/j.gastro.2025.07.013","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000}}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508524057871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508524057871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:53:51Z","timestamp":1762163631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508524057871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0016508524057871"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2024.11.023","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glepaglutide, a Long-Acting Glucagon-like Peptide-2 Analogue, Reduces Parenteral Support in Patients With Short Bowel Syndrome: A Phase 3 Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2024.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}